{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:13Z","timestamp":1786735813475,"version":"build-2736575974"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijem.ijem_292_19","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T03:22:42Z","timestamp":1570072962000},"page":"391","source":"Crossref","is-referenced-by-count":43,"title":["Secondary and tertiary hyperparathyroidism in chronic kidney disease: An endocrine and renal perspective"],"prefix":"10.4103","volume":"23","author":[{"given":"Manju","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.268496-1","first-page":"184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: A systematic review of the literature and available data","author":"Hedgeman","year":"2015","journal-title":"Int J Nephrol"},{"key":"key-10.4103\/2230-8210.268496-2","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;S1-130. doi: 10.1038\/ki. 2009.188."},{"key":"key-10.4103\/2230-8210.268496-3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199507273330407","article-title":"Calcium-ion-sensing cell-surface receptors","author":"Brown","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.268496-4","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"key-10.4103\/2230-8210.268496-5","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","author":"Quarles","year":"2008","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2230-8210.268496-6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","author":"Galitzer","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key-10.4103\/2230-8210.268496-7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"key-10.4103\/2230-8210.268496-8","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"key-10.4103\/2230-8210.268496-9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2230-8210.268496-10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","article-title":"Extracellular Ca2+sensing, regulation of parathyroid cell function, and role of Ca2+and other ions as extracellular ( first) messengers","author":"Brown","year":"1991","journal-title":"Physiol Rev"},{"key":"key-10.4103\/2230-8210.268496-11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0003-9861(73)90010-6","article-title":"The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus","author":"Tanaka","year":"1973","journal-title":"Arch Biochem Biophys"},{"key":"key-10.4103\/2230-8210.268496-12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2230-8210.268496-13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/11.supp3.130","article-title":"Pathogenesis of secondary hyperparathyroidism","author":"Slatopolsky","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11914-018-0486-0","article-title":"CKD-MBD: From the pathogenesis to the identification and development of potential novel therapeutic targets","author":"Elias","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"key-10.4103\/2230-8210.268496-15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the \u201ctrade-off\u201d hypothesis","author":"Guti\u00e9rrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.mnh.0000172717.49476.80","article-title":"Role of fibroblast growth factor 23 in health and in chronic kidney disease","author":"Fukagawa","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key-10.4103\/2230-8210.268496-17","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"key-10.4103\/2230-8210.268496-18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","author":"Meir","year":"2014","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/2230-8210.268496-20","first-page":"27","article-title":"The Klotho proteins in health and disease.Nature reviews","author":"Kuro-O","year":"2019","journal-title":"Nephrology"},{"key":"key-10.4103\/2230-8210.268496-21","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-22","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1681\/ASN.2016050585","article-title":"Let-7 and MicroRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism","author":"Shilo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-23","doi-asserted-by":"crossref","first-page":"40534","DOI":"10.1038\/srep40534","article-title":"Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease","author":"Kawakami","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/2230-8210.268496-24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"key-10.4103\/2230-8210.268496-25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","author":"Krajisnik","year":"2010","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","author":"Tokumoto","year":"2002","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-27","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1523-1755.2000.00370.x","article-title":"Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism","author":"Yano","year":"2000","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-29","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.268496-30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2230-8210.268496-31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","author":"Kestenbaum","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/2230-8210.268496-34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/1744-9987.12685","article-title":"Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients","author":"Tanaka","year":"2018","journal-title":"Ther Apher Dial"},{"key":"key-10.4103\/2230-8210.268496-35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","author":"Berson","year":"1963","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2230-8210.268496-36","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"key-10.4103\/2230-8210.268496-37","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.268496-38","first-page":"(102);S29","article-title":"Circulating PTH molecular forms: What we know and what we don't","author":"D'Amour","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/2230-8210.268496-39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/endo.142.4.8093","article-title":"Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH\/PTH-related peptide receptor","author":"Nguyen-Yamamoto","year":"2001","journal-title":"Endocrinology"},{"key":"key-10.4103\/2230-8210.268496-40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"key-10.4103\/2230-8210.268496-41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2008.01.017","article-title":"Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: A cross-sectional study","author":"Joly","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2230-8210.268496-42","first-page":"1137","article-title":"Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: Impact on clinical populations","author":"Cavalier","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"key-10.4103\/2230-8210.268496-43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1523-1755.2005.00513.x","article-title":"Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry","author":"Lehmann","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-44","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1053\/ajkd.2001.27436","article-title":"Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients","author":"Nakanishi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2230-8210.268496-45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2215\/CJN.01391005","article-title":"Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia","author":"Arakawa","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP64069","article-title":"Normalization of reversed bio-intact-PTH (1-84)\/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism","author":"Tanaka","year":"2005","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/2230-8210.268496-47","first-page":"iii59","article-title":"The whole-PTH\/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism","author":"Tanaka","year":"2008","journal-title":"NDT Plus"},{"key":"key-10.4103\/2230-8210.268496-48","first-page":"iii54","article-title":"Reversed whole PTH\/intact PTH ratio as an indicator of marked parathyroid enlargement: Five case studies and a literature review","author":"Komaba","year":"2008","journal-title":"NDT Plus"},{"key":"key-10.4103\/2230-8210.268496-49","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","author":"Kidney","year":"2017","journal-title":"Kidney int Suppl"},{"key":"key-10.4103\/2230-8210.268496-50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.268496-51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2215\/CJN.02830608","article-title":"Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: A randomized trial","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-52","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","author":"National","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2230-8210.268496-53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: A meta-analysis of randomized controlled trials","author":"Patel","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1159\/000362424","article-title":"Effect of niacin on FGF23 concentration in chronic kidney disease","author":"Rao","year":"2014","journal-title":"Am J Nephrol"},{"key":"key-10.4103\/2230-8210.268496-55","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1681\/ASN.2018101058","article-title":"Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: The combine trial","author":"Ix","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: A network meta-analysis of randomized trials","author":"Palmer","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2230-8210.268496-57","doi-asserted-by":"crossref","unstructured":"Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF, et al. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev 2009;CD005633. doi: 10.1002\/14651858.CD005633.pub2","DOI":"10.1002\/14651858.CD005633.pub2"},{"key":"key-10.4103\/2230-8210.268496-58","doi-asserted-by":"crossref","unstructured":"Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF, et al. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2009;CD008175. doi: 10.1002\/14651858.CD005633.pub2.","DOI":"10.1002\/14651858.CD005633.pub2"},{"key":"key-10.4103\/2230-8210.268496-59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.268496-60","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ndt\/gfg451","article-title":"Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism","author":"Okuno","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-61","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2015040468","article-title":"Ergocalciferol supplementation in hemodialysis patients with vitamin D deficiency: A randomized clinical trial","author":"Miskulin","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-62","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.268496-63","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ndt\/gft417","article-title":"Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects","author":"Martin","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: A randomized clinical trial","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.268496-66","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","author":"Behets","year":"2015","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-67","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: The evolve trial","author":"Moe","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-68","first-page":"2482","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","author":"EVOLVE","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.268496-69","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2215\/CJN.10390917","article-title":"Parathyroidectomy in the Management of Secondary Hyperparathyroidism","author":"Lau","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-70","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","article-title":"Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism","author":"Costa-Hong","year":"2007","journal-title":"Surgery"},{"key":"key-10.4103\/2230-8210.268496-72","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00268-006-0693-1","article-title":"Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism","author":"Trombetti","year":"2007","journal-title":"World J Surg"},{"key":"key-10.4103\/2230-8210.268496-73","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/2230-8210.268496-74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","author":"Jain","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key-10.4103\/2230-8210.268496-75","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: Still a challenge in the post-operative management of primary hyperparathyroidism: A systematic review of the literature","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.268496-76","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1046\/j.1442-2042.2001.00340.x","article-title":"Development of low-turnover bone diseases after parathyroidectomy and autotransplantation","author":"Yajima","year":"2001","journal-title":"Int J Urol"},{"key":"key-10.4103\/2230-8210.268496-77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1440-1797.2009.01257.x","article-title":"Prospective study on dialysis patients after total parathyroidectomy without autoimplant","author":"Chan","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"key-10.4103\/2230-8210.268496-78","doi-asserted-by":"crossref","first-page":"e0174811","DOI":"10.1371\/journal.pone.0174811","article-title":"The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study","author":"Hernandes","year":"2017","journal-title":"PloS One"},{"key":"key-10.4103\/2230-8210.268496-79","first-page":"412","article-title":"Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism","author":"Giangrande","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-80","first-page":"iii31","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","author":"Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-81","first-page":"iii47","article-title":"Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism","author":"Nakanishi","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2230-8210.268496-82","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"key":"key-10.4103\/2230-8210.268496-83","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","author":"Hern\u00e1ndez","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/2230-8210.268496-84","first-page":"287","article-title":"Long-term use of cinacalcet in kidney transplant recipients with hypercalcemic secondary hyperparathyroidism: A single-center prospective study","author":"Zavvos","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"key-10.4103\/2230-8210.268496-85","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.transproceed.2016.01.044","article-title":"Treatment of persistent hypercalcemia and hyperparathyroidism with cinacalcet after successful kidney transplantation","author":"Wa\u017cna-Jab\u0142o\u0144ska","year":"2016","journal-title":"Transplant Proc"},{"key":"key-10.4103\/2230-8210.268496-86","first-page":"71","article-title":"Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis","author":"Dulfer","year":"39;s","journal-title":"Langenbeck"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:33:55Z","timestamp":1786732435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.IJEM_292_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["268496"],"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_292_19","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}